Aveva Drug Delivery Announces FDA Approval for Generic Lidocaine Patch, Enhancing Pain Management Options Aveva Drug Delivery Systems has received FDA approval for its generic Lidocaine 1.8% Patch, a breakthrough in treating nerve pain with a focus on affordability and accessibility.

Aveva Drug Delivery Announces FDA Approval for Generic Lidocaine Patch, Enhancing Pain Management Options #USA #Miramar #Aveva_Drug_Delivery #DifGen #Generic_Lidocaine